Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Decide which cash back credit card you should get by assessing your spending habits. Find the best rewards for you.
15,590 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Joby Aviation is set to report Q4 2025 results after the close, and the focal point for investors is cash burn. The c...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
Shoe Carnival's Q1 2026 results offer early clues about its path through promotions, online growth, and inventory man...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
On May 29, markets extended their gains as Dell Technologies surged about 33% on better-than-expected earnings and AI...
As the Q4 2025 earnings season unfolds, savvy investors turn to transcripts to separate sound bites from real signal....
The software market's laggard this year may be near a tipping point. Snowflake's recent performance hints that AI-dri...
Nebius Group stock rocketing has traders buzzing. This guide breaks down the momentum, explains the drivers, and offe...
Oil markets jump on Middle East disruption fears, signaling durable upside for energy stocks. Analysts outline who co...
Speculative growth stocks Archer Aviation and Quantum Computing slid after earnings, as burn rates and macro headwind...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...